Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Zevia PBC (ZVIA) Stock Forecast & Price Prediction United States | NYSE | Consumer Defensive | Beverages - Non-Alcoholic
$1.67
-0.09 (-5.11%)Did ZVIA Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Zevia is one of their latest high-conviction picks.
Based on our analysis of 2 Wall Street analysts, ZVIA has a bullish consensus with a median price target of $4.00 (ranging from $1.25 to $6.00). The overall analyst rating is Strong Buy (8.9/10). Currently trading at $1.67, the median forecast implies a 139.5% upside. This outlook is supported by 5 Buy, 2 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for ZVIA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 26, 2026 | Telsey Advisory Group | Sarang Vora | Outperform | Maintains | $5.00 |
| Jan 14, 2026 | Telsey Advisory Group | Outperform | Maintains | $N/A | |
| Nov 6, 2025 | Telsey Advisory Group | Outperform | Maintains | $N/A | |
| Oct 29, 2025 | Telsey Advisory Group | Outperform | Maintains | $N/A | |
| Aug 14, 2025 | Telsey Advisory Group | Outperform | Maintains | $N/A | |
| Aug 12, 2025 | Morgan Stanley | Equal-Weight | Maintains | $N/A | |
| Aug 7, 2025 | BMO Capital | Outperform | Maintains | $N/A | |
| Aug 7, 2025 | Telsey Advisory Group | Outperform | Maintains | $N/A | |
| Aug 4, 2025 | Telsey Advisory Group | Outperform | Upgrade | $N/A | |
| May 8, 2025 | Telsey Advisory Group | Market Perform | Maintains | $N/A | |
| May 5, 2025 | Telsey Advisory Group | Market Perform | Maintains | $N/A | |
| Feb 27, 2025 | Telsey Advisory Group | Market Perform | Maintains | $N/A | |
| Jan 14, 2025 | Goldman Sachs | Neutral | Maintains | $N/A | |
| Jan 14, 2025 | Telsey Advisory Group | Market Perform | Maintains | $N/A | |
| Nov 7, 2024 | Telsey Advisory Group | Market Perform | Maintains | $N/A | |
| Nov 4, 2024 | Telsey Advisory Group | Market Perform | Maintains | $N/A | |
| May 9, 2024 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| May 9, 2024 | Telsey Advisory Group | Market Perform | Maintains | $N/A | |
| May 9, 2024 | Goldman Sachs | Neutral | Maintains | $N/A | |
| Feb 28, 2024 | Morgan Stanley | Equal-Weight | Maintains | $N/A |
The following stocks are similar to Zevia based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Zevia PBC has a market capitalization of $124.17M with a P/E ratio of -11.7x. The company generates $169.33M in trailing twelve-month revenue with a -4.1% profit margin.
Revenue growth is +21.2% quarter-over-quarter, while maintaining an operating margin of -0.3% and return on equity of -20.0%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Produces zero-calorie, naturally sweetened beverages.
Zevia PBC generates revenue by selling a variety of zero-calorie beverages, including sodas, energy drinks, mixers, and teas, primarily utilizing stevia as a sweetener. The company targets health-conscious consumers who are looking for alternatives to sugary drinks, thus positioning itself within the growing health and wellness market.
With a commitment to non-GMO, vegan, and gluten-free products, Zevia PBC appeals to a niche market that values clean-label and sustainable options. As consumer preferences shift towards healthier choices, Zevia is expanding its distribution in supermarkets and health food stores across North America, aiming to capture a larger share of the non-alcoholic beverage industry.
Consumer Defensive
Beverages - Non-Alcoholic
91
Mr. Alexandre I. Ruberti
United States
2021
Zevia PBC has appointed Alexandre Ruberti as President and CEO, effective immediately, following the resignation of Amy Taylor. Ruberti remains on the Board of Directors.
Leadership changes can impact company strategy, investor confidence, and stock performance. Rubertiโs experience may signal a shift toward growth or operational improvements for Zevia.
Zevia is showing double-digit sales growth and narrowed losses, with strong brand appeal. The stock is undervalued at a 0.6x price-to-sales ratio, supported by expanded distribution and innovative marketing.
Zeviaโs turnaround shows promise with sales growth and reduced losses. Its low price-to-sales ratio suggests upside potential, supported by strong brand appeal and effective marketing strategies.
Zevia PBC (NYSE: ZVIA) has appointed Brian Bousley as Executive VP and Chief Commercial Officer, overseeing sales and distribution, effective immediately.
Zevia's appointment of a new Chief Commercial Officer signals a strategic move to enhance sales and distribution, potentially boosting revenue and market position, impacting investor sentiment.
Tourlite Capital maintains ~80% idiosyncratic risk despite higher net exposure. Montana Aerospace trades under 7x 2027E EBITDA, while FTAI Aviation's market share in CFM56 aftermarket rose to 12%.
Tourlite Capital's stable idiosyncratic risk alongside Montana Aerospace's low valuation signals potential undervaluation, while FTAI Aviation's market share growth indicates strong competitive positioning.
Zevia PBC (ZVIA) participated in the Goldman Sachs Global Staples Forum, presenting insights and updates relevant to investors.
Zevia's presentation at a major investment forum signals potential growth opportunities and investor interest, impacting stock performance and market perception.
Zevia PBC (ZVIA) held its Q1 2026 earnings call, discussing financial results and business performance. Details on revenue, expenses, and future outlook were provided.
Zevia's Q1 2026 earnings call provides insights into financial performance, growth strategies, and market trends, influencing investor sentiment and stock valuation.
Based on our analysis of 2 Wall Street analysts, Zevia PBC (ZVIA) has a median price target of $4.00. The highest price target is $6.00 and the lowest is $1.25.
According to current analyst ratings, ZVIA has 5 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.67. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict ZVIA stock could reach $4.00 in the next 12 months. This represents a 139.5% increase from the current price of $1.67. Please note that this is a projection by Wall Street analysts and not a guarantee.
Zevia PBC generates revenue by selling a variety of zero-calorie beverages, including sodas, energy drinks, mixers, and teas, primarily utilizing stevia as a sweetener. The company targets health-conscious consumers who are looking for alternatives to sugary drinks, thus positioning itself within the growing health and wellness market.
The highest price target for ZVIA is $6.00 from at , which represents a 259.3% increase from the current price of $1.67.
The lowest price target for ZVIA is $1.25 from at , which represents a -25.1% decrease from the current price of $1.67.
The overall analyst consensus for ZVIA is bullish. Out of 2 Wall Street analysts, 5 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $4.00.
Stock price projections, including those for Zevia PBC, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.